Doxazosin
Product Images NDC 53808-0364

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 53808-0364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image For 4mg (Doxazosin 4mg(apotex))

Label Image For 4mg (Doxazosin 4mg(apotex))
This is a label of a medication called Doxazosin Mesylate in tablet form with a strength of 4mg. The medication is distributed by RK Oy and comes in a package of 30 tablets. The lot number of the medication is JG1758 with a 100% lot of ROS2406P, and the expiration date is 03/31/2010. The medication is packaged by DOH Central Pharmacy located in Tallahassee, FL, and can be identified using the UPC code 360305000303.*
FDA Label Image

Chemical Structure (Doxazosin Image01)

Chemical Structure (Doxazosin Image01)
FDA Label Image

Table 1 (Doxazosin Image02)

Table 1 (Doxazosin Image02)
This text describes the results of three studies conducted to evaluate the efficacy of Doxazosin, a medication used to treat benign prostatic hyperplasia (BPH), a condition affecting the prostate gland in men causing urinary problems. The studies measure the maximum flow rate and symptom score before and after treatment with Doxazosin or Placebo. The results of each study are shown in a table that includes the number of participants, mean baseline and change in maximum flow rate, and modified questionnaire scores.*
FDA Label Image

Figure 1–study 1 (Doxazosin Image03)

Figure 1–study 1 (Doxazosin Image03)
The text contains some statistical data related to a study. It displays a graph showing the mean change in total symptom score over a certain period of time, as well as the mean increase in maximum urinary flow rate from baseline. The x-axis indicates the duration of treatment in weeks. However, without more information about the topic or context, it is difficult to provide a more specific description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.